Cell growth regulation

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 245-268

  Karunagaran, Devarajan ^a   Joseph, Jeena ^b   Santhosh Kumar, Thankayyan R ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELECOXIB; CELL CYCLE PROTEIN; CISPLATIN; CURCUMIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; FLUOROURACIL; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOTRETINOIN; JANUS KINASE; MELPHALAN; NAVELBINE; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53; RESVERATROL; RETINOIC ACID; STAT PROTEIN; TELOMERASE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; BREAST TUMOR; CANCER CHEMOTHERAPY; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL GROWTH; COLON CANCER; COMBINATION CHEMOTHERAPY; DNA SYNTHESIS INHIBITION; DOWN REGULATION; DRUG POTENTIATION; ENZYME INHIBITION; GROWTH REGULATION; HUMAN; MELANOMA; MONOTHERAPY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; UPREGULATION;

CURCUMA LONGA;

EID: 84934443358     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_11     Document Type: Review

References (119)

1. S. Shishodia, G. Sethi, and B. B. Aggarwal, Curcumin: getting back to the roots. Ann NY Acad Sci 1056, 206-217 (2005).
2. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, Multiple biological activities of curcumin: A short review. Life Sci 78, 2081-2087 (2006).
3. M. Notoya, H. Nishimura, J. T. Woo, K. Nagai, Y. Ishihara, and H. Hagiwara, Curcumin inhibits the proliferation and mineralization of cultured osteoblasts. Eur J Pharmacol 534, 55-62 (2006).
4. J. S. Shim, J. Lee, H. J. Park, S. J. Park, and H. J. Kwon, A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function. Chem Biol 11, 1455-1463 (2004).
5. T. Choudhuri, S. Pal, T. Das, and G. Sa, Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280, 20,059-20,068 (2005).
6. Y. K. Kwon, J. M. Jun, S. W. Shin, J. W. Cho, and S. I. Suh, Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells. Int J Oncol 26, 1597-1603 (2005).
7. A. Chen and J. Xu, Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288, G447-G456 (2005).
8. B. K. Batth, R. Tripathi and U. K. Srinivas, Curcumin-induced differentiation of mouse embryonal carcinoma PCC4 cells. Differentiation 68, 133-140 (2001).
9. F. Shen, X. Fan, B. Liu, X. Jia, H. Du, B. You, M. Ye, C. Huang,. and X. Shi, Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway. Toxicol Lett 160, 185-195 (2006).
10. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, K. Ohshiro, and N. Mori, Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118, 765-772 (2006).
11. M. Sun, Y. Yang, H. Li, B. Su, Y. Lu, Q. Wei, and T. Fan, [The effect of curcumin on bladder cancer cell line EJ in vitro]. Zhong Yao Cai 27, 848-850 (2004).
12. S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269-1279 (2003).
13. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappaBand IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053-1062 (2003).
14. A. K. Singh, G. S. Sidhu, T. Deepa, and R. K. Maheshwari, Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett 107, 109-115 (1996).
15. H. W. Chen and H. C. Huang, Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol 124, 1029-1040 (1998).
16. Y. Wu, Y. Chen, J. Xu, and L. Lu, Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi 24, 348-352 (2002).
17. S. Aggarwal, Y. Takada, S. Singh, J. N. Myers, and B. B. Aggarwal, Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 111, 679-692 (2004).
18. S. Shishodia, H. M. Amin, R. Lai, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70, 700-713 (2005).
19. H. Chen, Z. S. Zhang, Y. L. Zhang, and D.Y. Zhou, Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19, 3675-3680 (1999).
20. D. Morin, S. Barthelemy, R. Zini, S. Labidalle, and J. P. Tillement, Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett 495, 131-136 (2001).
21. M. Zheng, S. Ekmekcioglu, E. T. Walch, C. H. Tang, and E. A. Grimm, Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14, 165-171 (2004).
22. M. J. Van Erk, E. Teuling, Y. C. Staal, S. Huybers, P. J. Van Bladeren, J. M. Aarts, and B. Van Ommen, Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog 3, 8 (2004).
23. A. S. Jaiswal, B P. Marlow, N. Gupta, and S. Narayan, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414-8427 (2002).
24. A. Khafif, R. Hurst, K. Kyker, D. M. Fliss, Z. Gil, and J. E. Medina, Curcumin: A new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 132, 317-321 (2005).
25. J. M. Holy, Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518, 71-84 (2002).
26. C. Yan, M. S. Jamaluddin, B. Aggarwal, J. Myers, and D. D. Boyd, Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 4, 233-241 (2005).
27. C. Ramachandran, H. B. Fonseca, P. Jhabvala, E. A. Escalon, and S. J. Melnick, Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett 184, 1-6 (2002).
28. K. Mehta, P. Pantazis, T. McQueen, and B. B.Aggarwal, Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8, 470-481 (1997).
29. E. L. White, L. J. Ross, S. M. Schmid, G. J. Kelloff, V. E. Steele, and D. L. Hill, Screening of potential cancer-preventing chemicals for inhibition of induction of ornithine decarboxylase in epithelial cells from rat trachea. Oncol Rep 5, 717-722 (1998).
30. M. Hasmeda and G. M. Polya, Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42, 599-605 (1996).
31. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A, H, Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813-819 (1991).
32. A. Nagao, M. Maeda, B. P. Lim, H. Kobayashi, and J. Terao, Inhibition of beta-carotene-15,15′-dioxygenase activity by dietary flavonoids. J Nutr Biochem 11, 348-355 (2000).
33. R. L. Hong, W. H. Spohn, and M. C. Hung, Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 5, 1884-1891 (1999).
34. S. C. Gautam, Y. X. Xu, K. R. Pindolia, N. Janakiraman, and R. A. Chapman, Non-selective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem Pharmacol 55, 1333-1337 (1998).
35. A. Khar, A. M. Ali, B. V. Pardhasaradhi, C. H. Varalakshmi, R. Anjum, and A. L. Kumari, Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 6, 368-376 (2001).
36. M. C. Jiang, H. F. Yang-Yen, J. J. Yen, and J. K. Lin, Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26, 111-120 (1996).
37. C. Sun, X. Liu, Y. Chen, and F. Liu, Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma. J Huazhong Univ Sci Technolog Med Sci 25, 404-407 (2005).
38. D. Karunagaran, R. Rashmi, and T. R. Kumar, Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5, 117-129 (2005).
39. J. A. Bush, K. J. Cheung, Jr., and G. Li, Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305-314 (2001).
40. L. Moragoda, R. Jaszewski, and A. P. Majumdar, Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res 21, 873-878 (2001).
41. R. Rashmi, T. R. Santhosh Kumar, and D. Karunagaran, Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 538, 19-24 (2003).
42. S. Uddin, A. R. Hussain, P. S. Manogaran, K. Al-Hussein, L. C. Platanias, M. I. Gutierrez, and K. G. Bhatia, Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 24, 7022-7030 (2005).
43. R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal, Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150 (2002).
44. M. L. Kuo, T. S. Huang, and J. K. Lin, Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317, 95-100 (1996).
45. R. Rashmi, S. Kumar, and D. Karunagaran, Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis 25, 179-187 (2004).
46. R. Rashmi, S.Kumar, S. and Karunagaran, D. (2004a) Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it. Carcinogenesis 25, 1867-1877 (2004).
47. M. Shi, Q. Cai, L. Yao, Y. Mao, Y. Ming, and G. Ouyang, Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int (2006).
48. G. Radhakrishna Pillai, A. S. Srivastava, T. I. Hassanein, D. P. Chauhan, and E. Carrier, Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208, 163-170 (2004).
49. R. Anjum and A. Khar, Differential regulation of apoptosis in AK-5 tumor cells by the proto-oncogene Bcl-2: presence of Bcl-2 dependent and independent pathways. FEBS Lett 499, 166-170 (2001).
50. S. Pal, T. Choudhuri, S. Chattopadhyay, A. Bhattacharya, G. K. Datta, T. Das, and G. Sa, Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem Biophys Res Commun 288, 658-665 (2001).
51. R. Rashmi, S. Kumar, and D. Karunagaran, Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26, 713-723 (2005).
52. G. Song, Y. B. Mao, Q. F. Cai, L. M. Yao, G. L. Ouyang, and S. D. Bao, Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38, 1791-1798 (2005).
53. L. D. Zheng, Q. S. Tong, K. X. Tao, L. Wang, and B. Zhang, [Effects of Smac gene overexpression on chemotherapeutic sensitivity of gastric cancer cell line MKN-45]. Ai Zheng 23, 361-366 (2004).
54. Q. Wang, A. Y. Sun, A. Simonyi, M. D. Jensen, P. B. Shelat, G. E. Rottinghaus, R. S. MacDonald, D. K. Miller, D. E. Lubahn, G. A.Weisman, and G. Y. Sun, Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res 82, 138-148 (2005).
55. A. Sood, R. Mathew, and H. Trachtman, Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin. Biochem Biophys Res Commun 283, 36-41 (2001).
56. M. Shakibaei, G. Schulze-Tanzil, T. John, and A. Mobasheri, Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: An immunomorphological study. Ann Anat 187, 487-497 (2005).
57. S. Fujisawa, T. Atsumi, M. Ishihara, and Y. Kadoma, Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res 24, 563-569 (2004).
58. A. C. Reddy and B. R. Lokesh, Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 137, 1-8 (1994).
59. V. K. Shalini and L. Srinivas, Lipid peroxide induced DNA damage: Protection by turmeric (Curcuma longa). Mol Cell Biochem 77, 3-10 (1987).
60. M. Subramanian, M. N. Sreejayan, Rao, T. P. Devasagayam, and B. B. Singh, Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat Res 311, 249-255 (1994).
61. A. C. Reddyand B. R. Lokesh, Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 32, 279-283 (1994).
62. E. L. White, L. J. Ross, S. M. Schmid, G. J. Kelloff, V. E. Steele, and D. L. Hill, Screening of potential cancer preventing chemicals for induction of glutathione in rat liver cells. Oncol Rep 5, 507-512 (1998).
63. H. Ahsan, N. Parveen, N. U. Khan, and S. M. Hadi, Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 121, 161-175 (1999).
64. S. Bhaumik, R. Anjum, N. Rangaraj, B. V. Pardhasaradhi, and A. Khar, Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456, 311-314 (1999).
65. U. Jacobi, T. Tassopoulos, C. Surber, and J. Lademann, Cutaneous distribution and localization of dyes affected by vehicles all with different lipophilicity. Arch Dermatol Res 297, 303-310 (2006).
66. A. Paradkar, A. A. Ambike, B. K. Jadhav, and K R. Mahadik,) Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm 271, 281-286 (2004).
67. K. U. Schallreuter and H. Rokos, Turmeric (curcumin): A widely used curry ingredient, can contribute to oxidative stress in Asian patients with acute vitiligo. Indian J Dermatol Venereol Leprol 72, 57-59 (2006).
68. M. Moussavi, K. Assi, A. Gomez-Munoz, and B. Salh, Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis 27, 1636-1644 (2006).
69. C. Syng-Ai, A. L. Kumari, and A. Khar, Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3, 1101-1108 (2004).
70. S. Somasundaram, N. A. Edmund, D. T. Moore, G. W. Small, Y. Y. Shi, and R. Z. Orlowski, Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 62, 3868-3875 (2002).
71. M. S. Ahmad, Sheeba, and M Afzal, Amelioration of genotoxic damage by certain phytoproducts in human lymphocyte cultures. Chem Biol Interact 149, 107-115 (2004).
72. E. Sikora, A. Bielak-Zmijewska, K. Piwocka, J. Skierski, J. and E. Radziszewska, Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54, 899-907 (1997).
73. B. B. Aggarwal, Y. Takada, and O. V. Oommen, From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Invest Drugs 13, 1327-1338 (2004).
74. C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163, 3474-3483 (1999).
75. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24,995-25,000 (1995).
76. S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195-206 (2006).
77. D. R. Siwak, S. Shishodia, B. B. Aggarwal, and R. Kurzrock, Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104, 879-890 (2005).
78. A. Duvoix, F. Morceau, S. Delhalle, M. Schmitz, M. Schnekenburger, M. M. Galteau, M. Dicato, and M. Diederich, Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol 66, 1475-1483 (2003).
79. B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos, and P. E. Price, Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490-7498 (2005).
80. R. J. Anto, T. T. Maliekal, and D. Karunagaran, l-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosis. J Biol Chem 275, 15,601-15,604 (2000).
81. D. Deeb, H. Jiang, X. Gao, M. S. Hafner, H. Wong, G. Divine, R. A. Chapman, S. A. Dulchavsky, andS. C. Gautam, Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther 3, 803-812 (2004).
82. D. Deeb, Y. X. Xu, H. Jiang, X. Gao, N. Janakiraman, R. A. Chapman, and S. C. Gautam, Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2, 95-103 (2003).
83. S.V. Bava, V. T. Puliappadamba, A. Deepti, A. Nair, D. Karunagaran, and R. J. Anto, Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol Chem 280, 6301-6308 (2005).
84. M. Shi, Q. Cai, L. Yao, Y. Mao, Y. Ming,.and G. Ouyang, Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30, 221-226 (2006).
85. W. Henke, K. Ferrell, D. Bech-Otschir, M. Seeger, R. Schade, P. Jungblut, M. Naumann, and W. Dubiel,) Comparison of human COP9 signalsome and 26S proteasome lid'. Mol Biol Rep 26, 29-34 (1999).
86. J. Rajasingh, H. P. Raikwar, G. Muthian, C. Johnson, and J. J. Bright, Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun 340, 359-368 (2006).
87. A. C. Bharti, N. Donato, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863-3871 (2003).
88. C. S. Divya and M. R. Pillai, Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45, 320-332 (2006).
89. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, and N. Mori, Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30, 313-321 (2006).
90. C. Bernt, T.Vennegeerts, U. Beuers, and C. Rust, The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis. Biochem Biophys Res Commun 340, 800-806 (2006).
91. Y. R. Chen and T. H. Tan, Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173-178 (1998).
92. A. R. Hussain, M. Al-Rasheed, P. S. Manogaran, K. A. Al-Hussein, L. C. Platanias, K. A. Kuraya, and S. Uddin, Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in Acute T cell Leukemias. Apoptosis 11, 245-254 (2006).
93. L. R. Chaudhary and K. A. Hruska, Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem 89, 1-5 (2003).
94. L. Korutla and P. Kumar, Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224, 597-600 (1994).
95. A. Chen, J. Xu, and A. C. Johnson, Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25, 278-287 (2006).
96. D. W. Scott and G. Loo, Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis 25, 2155-2164 (2004).
97. GP. Collett and F. C. Campbell, Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25, 2183-2189 (2004).
98. S. Zheng and A. Chen, Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 384, 149-157 (2004).
99. S. Zheng and A. Chen, Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290, G883-893 (2005).
100. L. Zheng, Q. Tong, and C. Wu, Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms. J Huazhong Univ Sci Technolog Med Sci 24, 55-58 (2004).
101. S. Sen, H. Sharma, and N. Singh, Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331, 1245-1252 (2005).
102. T. C. Hour, J. Chen, C. Y. Huang, J. Y. Guan, S. H. Lu, and Y. S. Pu, Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51, 211-218 (2002).
103. M. M. Chan, D. Fong, K. J. Soprano, W. F. Holmes, and H. Heverling, Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 194, 63-70 (2003).
104. J. Y. Koo, H. J. Kim, K. O. Jung, and K. Y. Park, Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food 7, 117-121 (2004).
105. B. Du, L. JiangQ. Xia, and L. Zhong, Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29. Chemotherapy 52, 23-28 (2006).
106. P. Limtrakul, S. Anuchapreeda, and D. Buddhasukh, Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13 (2004).
107. S. E. Chuang, P. Y. Yeh, Y. S. Lu, G. M. Lai, C. M. Liao, M. Gao, and A. L. Cheng, Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 63, 1709-1716 (2002).
108. S. Lev-Ari, L. Strier, D. Kazanov, O. Elkayam, D. Lichtenberg, D. Caspi, and N. Arber, Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford) 45, 171-177 (2006).
109. T. O. Khor, Y. S. Keum, W. Lin, J. H. Kim, R. Hu, G. Shen, C. Xu, A. Gopalakrishnan, B. Reddy, X. Zheng, A. H. Conney, and A. N. Kong, Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66, 613-621 (2006).
110. J. H. Kim, C. Xu, Y. S. Keum, B. Reddy, A. Conney, and A. N. Kong, Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with {beta}-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27, 475-482 (2006).
111. A. Spingarn, P. G. Sacks, D. Kelley, A. J. Dannenberg, and S. P. Schantz,) Synergistic effects of 13-cis retinoic acid and arachidonic acid cascade inhibitors on growth of head and neck squamous cell carcinoma in vitro. Otolaryngol Head Neck Surg 118, 159-164 (1998).
112. Y. Liu, R. L. Chang, X. X. Cui, H. L. Newmark, and A. H. Conney, Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol Res 9, 19-29 (1997).
113. D. Chendil, R. S. Ranga, D. Meigooni, S. Sathishkumar, and M. M. Ahmed, Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23, 1599-1607 (2004).
114. C. Ramachandran, S. Rodriguez, R. Ramachandran, P. K. Raveendran Nair, H. Fonseca, Z. Khatib, E. Escalon, and S. J. Melnick, Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25, 3293-3302 (2005).
115. B. K. .Adams, J. Cai, J. Armstrong, M. Herold, Y. J. Lu, A. Sun, J. P. Snyder, D. C. Liotta, D.P. Jones, and M. Shoji, EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 16, 263-275 (2005).
116. M. S. Furness, T. P. Robinson, T. Ehlers, R. B. T. Hubbard, J. L. Arbiser, D. J. Goldsmith, and J. P.Bowen, Antiangiogenic agents: Studies on fumagillin and curcumin analogs. Curr Pharm Des 11, 357-373 (2005).
117. Q. S. Tong, L. D. Zheng, P. Lu, F. C. Jiang, F. M. Chen, F. Q. Zeng, L.Wang, and J. H. Dong, Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells. Anticancer Drugs 17, 279-287 (2006).
118. W. M.Weber, L. A. Hunsaker, S. F. Abcouwer, L. M. Deck, and D. L.Vander Jagt, Antioxidant activities of curcumin and related enones. Bioorg Med Chem 13, 3811-3820 (2005).
119. K. M. Youssef and M. A. El-Sherbeny, Synthesis and antitumor activity of some curcumin analogs. Arch Pharm (Weinheim) 338, 181-189 (2005).